IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knott David M Jr

Q1 2024 Holdings

Filed 2024-05-14 | 114 holdings | $29.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Bridgebio Pharma, Inc.(BBIO)Common10806X102$495.0K16,0001.7%
Corteva, Inc.(CTVA)Common22052L104$667.0K11,5632.3%
AbbVie Inc.(ABBV)Common00287Y109$917.0K5,0373.1%
Catalyst Pharmaceuticals, Inc.(CPRX)Common14888U101$3.0M187,85210.3%
Ardelyx, Inc.(ARDX)Common039697107$6.0M825,00020.7%
Alphabet Inc(GOOG)Common02079K107$17.1M112,22058.5%
PreviousPage 3 of 3